piperaquine has been researched along with podophyllotoxin in 1 studies
Studies (piperaquine) | Trials (piperaquine) | Recent Studies (post-2010) (piperaquine) | Studies (podophyllotoxin) | Trials (podophyllotoxin) | Recent Studies (post-2010) (podophyllotoxin) |
---|---|---|---|---|---|
638 | 227 | 497 | 3,119 | 226 | 782 |
Protein | Taxonomy | piperaquine (IC50) | podophyllotoxin (IC50) |
---|---|---|---|
nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 2.145 | |
Tubulin alpha-1A chain | Sus scrofa (pig) | 0.6733 | |
Tubulin beta chain | Sus scrofa (pig) | 0.622 | |
Glucocorticoid receptor | Homo sapiens (human) | 0.014 | |
Tubulin beta-4A chain | Homo sapiens (human) | 1.7233 | |
Tubulin beta chain | Homo sapiens (human) | 1.7233 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.6 | |
Tubulin alpha-3C chain | Homo sapiens (human) | 1.7233 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 4 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 5 | |
Tubulin alpha-1B chain | Homo sapiens (human) | 1.7233 | |
Tubulin alpha-4A chain | Homo sapiens (human) | 1.7233 | |
Tubulin beta-4B chain | Homo sapiens (human) | 1.7233 | |
Tubulin beta-3 chain | Homo sapiens (human) | 1.7233 | |
Tubulin beta-2A chain | Homo sapiens (human) | 1.7233 | |
Tubulin beta-8 chain | Homo sapiens (human) | 1.7233 | |
Calcium-activated potassium channel subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.56 | |
Tubulin beta-2B chain | Bos taurus (cattle) | 0.8685 | |
Tubulin alpha-3E chain | Homo sapiens (human) | 1.7233 | |
Tubulin alpha-1A chain | Homo sapiens (human) | 1.7233 | |
Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 0.907 | |
Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 0.7744 | |
Tubulin alpha-1C chain | Homo sapiens (human) | 1.7233 | |
Tubulin beta-6 chain | Homo sapiens (human) | 1.7233 | |
Tubulin beta-2B chain | Homo sapiens (human) | 1.7233 | |
Tubulin beta-1 chain | Homo sapiens (human) | 1.7233 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Becker, K; Davioud-Charvet, E; Friebolin, W; Furrer, J; Jannack, B; Lanzer, M; Oeser, T; Sanchez, CP; Wenzel, N; Yardley, V | 1 |
1 other study(ies) available for piperaquine and podophyllotoxin
Article | Year |
---|---|
Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparum.
Topics: Animals; Antimalarials; Biological Transport; Cell Line, Tumor; Chloroquine; Drug Resistance; Drug Therapy, Combination; Glutathione Reductase; Humans; In Vitro Techniques; Malaria; Mice; Mice, Inbred BALB C; Naphthalenes; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship | 2008 |